Sanford Health, Sioux Falls, USA, is enrolling patients for a clinical trial using a less-invasive method to treat thoracoabdominal aortic aneurysms. Patrick Kelly, medical director of Sanford Vascular Services, Sanford Wound Clinic and the Sanford Advanced Aortic Program, Sioux Falls, USA, developed the investigational device and associated surgical procedure.
Kelly’s custom stent graft system, described in a recently published article in the Journal of Vascular Surgery, seals thoracoabdominal aneurysms. The device’s safety profiled will be examined in the clinical trial. The study will be performed under a physician-sponsored investigational device exemption. Patients must meet requirements related to the location, size, history of growth and risk of rupture of their aneurysm. Enrolees must also be older than 18 and have a life expectancy greater than one year.
This less-invasive method is important for patients who, for various reasons, are not candidates for more invasive methods of treatment and are limited in care options, said Kelly.
The trial, based out of Sioux Falls, is part of Sanford Health’s Advanced Aortic Program, which provides diagnosis, second opinions and non-invasive treatments for diseases and disorders of the arteries, veins and lymphatic system outside of the heart.